Who are NovoCure's investors?

NovoCure's investors include Pfizer Venture Investments, Windham Capital Partners.

NovoCure

NASDAQ: NVCR

Founded 2000 · 2 known investors

Novocure is a global oncology company developing Tumor Treating Fields therapies, including its Optune Pax device, to treat aggressive cancers such as locally advanced pancreatic cancer. It serves cancer patients and their treating physicians in the medical device and healthcare sector.

BiotechHealthtechMedical Devices

Investors · 2

Pfizer Venture Investments$5M – $20M

Windham Capital PartnersNew York · $1M – $5M

Competitors · 1

by search overlap

Onkure Therapeutics Inc41 shared keywordsOnKure Therapeutics is a clinical-stage biopharmaceutical company developing PI3Kα pan-mutant selective inhibitor medicines for the treatment of breast cancer and vascular anomalies. Its focus is on selective, allosteric small-molecule oncology therapeutics.

Companies competing with NovoCure for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

What’s Behind NovoCure (NVCR) Shares Climbing Today? - Simply Wall St Newssimplywall.st · Aug 2026

NovoCure Limited (NVCR) Stock Analysis: Exploring A 77% Potential Upside In The Healthcare Sectordirectorstalkinterviews.com · Aug 2026

NovoCure's Clean Beat Signals A Shift Toward Profitability (Rating Upgrade) (NASDAQ:NVCR) | Seeking Alphaseekingalpha.com · Jul 2026

Frequently asked questions

What does NovoCure do?: Novocure is a global oncology company developing Tumor Treating Fields therapies, including its Optune Pax device, to treat aggressive cancers such as locally advanced pancreatic cancer. It serves cancer patients and their treating physicians in the medical device and healthcare sector.
Who are NovoCure's investors?: NovoCure's investors include Pfizer Venture Investments, Windham Capital Partners.